aspirin has been researched along with Albuminuria in 25 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Albuminuria: The presence of albumin in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effect of aspirin use in low-risk pregnancy on: (1) pregnancy-associated plasma protein-A (PAPP-A) and placental-like growth factor (PLGF); (2) urinary albumin-to-creatinine ratio (ACR) and blood pressure; (3) fetal growth parameters; and (4) placental histopathology." | 9.30 | Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT. ( Clarke, P; Culliton, M; Downey, P; Fitzgerald, D; Maguire, OC; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Mooney, EE; Mulcahy, C; Tully, E, 2019) |
| "Forty patients who had diabetes with nephropathy and arteriosclerosis obliterans and had already been treated with angiotensin II receptor blocker (n = 40) were randomly assigned to sarpogrelate (300 mg/d; n = 20) or aspirin group (100 mg/d; n = 20)." | 9.13 | Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes. ( Ishizuka, T; Ito, S; Mori, T; Nako, K; Ogawa, S, 2008) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 9.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "To assess the effect of aspirin use in low-risk pregnancy on: (1) pregnancy-associated plasma protein-A (PAPP-A) and placental-like growth factor (PLGF); (2) urinary albumin-to-creatinine ratio (ACR) and blood pressure; (3) fetal growth parameters; and (4) placental histopathology." | 5.30 | Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT. ( Clarke, P; Culliton, M; Downey, P; Fitzgerald, D; Maguire, OC; Malone, FD; McAuliffe, FM; McParland, P; Mone, F; Mooney, EE; Mulcahy, C; Tully, E, 2019) |
| "Forty patients who had diabetes with nephropathy and arteriosclerosis obliterans and had already been treated with angiotensin II receptor blocker (n = 40) were randomly assigned to sarpogrelate (300 mg/d; n = 20) or aspirin group (100 mg/d; n = 20)." | 5.13 | Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes. ( Ishizuka, T; Ito, S; Mori, T; Nako, K; Ogawa, S, 2008) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 5.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "Previous studies have demonstrated that urinary thromboxane B2 (TXB2) excretion (UTXB2) and glomerular production of TXB2 are enhanced in experimental diabetes and that selective inhibitors of TX synthesis prevent or delay the development of albuminuria." | 3.68 | Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat. ( Craven, PA; DeRubertis, FR, 1992) |
| "Low-dose Aspirin inhibits thromboxane A2 with minimal effects on prostacyclin and induces clinical improvements in pre-eclampsia." | 3.68 | Treatment of severe pre-eclampsia by acetyl salicylic acid. ( Abd-Rabbo, S; Khowessah, M; Shaala, S; Toppozada, M; Zoheir, A, 1991) |
| "Careful counseling of women with diabetic nephropathy before pregnancy with estimation of the risk for the mother and fetus is important." | 2.48 | Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. ( Clausen, P; Damm, P; Feldt-Rasmussen, B; Mathiesen, ER; Ringholm, L, 2012) |
| "Therefore, prevention and treatment of diabetic nephropathy has become a prominent goal in the treatment of patients with diabetes mellitus." | 2.42 | Prevention and treatment of diabetic nephropathy in older patients. ( Jungmann, E, 2003) |
| "Aspirin was used in 64% of patients with CAD and in 28." | 1.35 | Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive. ( Garg, P; Jeevanantham, V; Khan, A; Nautiyal, A; Reddy, PC; Shrivastava, R, 2008) |
| "But aspirin therapy was used in only 35 cases (32." | 1.33 | The rate of checking urine microalbumin and aspirin primary prevention in type 2 DM. ( Limpawattana, P; Mahankkanukrauh, A; Sawanyawisuth, K; Wongvipaporn, C, 2006) |
| "Aspirin was used regularly by 37% of those with CVD and by 13% of those with risk factors only Adjusted odds of regular aspirin use were significantly greater for individuals with CVD than for those with one CVD risk factor (odds ratio [OR] = 4." | 1.31 | Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. ( Fagot-Campagna, A; Narayan, KM; Rolka, DB, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walker, RG | 1 |
| Wolfe, R | 1 |
| Bongetti, E | 1 |
| Polkinghorne, KR | 1 |
| Woods, RL | 1 |
| Ryan, J | 1 |
| Espinoza, S | 1 |
| Murray, A | 1 |
| Ernst, ME | 1 |
| Mcneil, JJ | 1 |
| Ma, KL | 1 |
| Liu, L | 1 |
| Zhang, Y | 1 |
| Wang, GH | 1 |
| Hu, ZB | 1 |
| Chen, PP | 1 |
| Lu, J | 1 |
| Lu, CC | 1 |
| Gong, TK | 1 |
| Gong, YX | 1 |
| Liu, BC | 1 |
| Mone, F | 1 |
| Mulcahy, C | 1 |
| McParland, P | 1 |
| Downey, P | 1 |
| Culliton, M | 1 |
| Maguire, OC | 1 |
| Mooney, EE | 1 |
| Clarke, P | 1 |
| Fitzgerald, D | 1 |
| Tully, E | 1 |
| Malone, FD | 1 |
| McAuliffe, FM | 1 |
| Zaccardi, F | 1 |
| Rizzi, A | 1 |
| Petrucci, G | 1 |
| Ciaffardini, F | 1 |
| Tanese, L | 1 |
| Pagliaccia, F | 1 |
| Cavalca, V | 1 |
| Ciminello, A | 1 |
| Habib, A | 1 |
| Squellerio, I | 1 |
| Rizzo, P | 1 |
| Tremoli, E | 1 |
| Rocca, B | 1 |
| Pitocco, D | 1 |
| Patrono, C | 1 |
| Yassine, HN | 1 |
| Davis-Gorman, G | 1 |
| Stump, CS | 1 |
| Thomson, SS | 1 |
| Peterson, J | 1 |
| McDonagh, PF | 1 |
| Crasto, W | 1 |
| Jarvis, J | 1 |
| Khunti, K | 1 |
| Skinner, TC | 1 |
| Gray, LJ | 1 |
| Brela, J | 1 |
| Troughton, J | 1 |
| Daly, H | 1 |
| Lawrence, IG | 1 |
| McNally, PG | 1 |
| Carey, ME | 1 |
| Davies, MJ | 1 |
| Mathiesen, ER | 1 |
| Ringholm, L | 1 |
| Feldt-Rasmussen, B | 1 |
| Clausen, P | 1 |
| Damm, P | 1 |
| Gaede, P | 1 |
| Hansen, HP | 2 |
| Parving, HH | 2 |
| Pedersen, O | 1 |
| Jungmann, E | 1 |
| Sawanyawisuth, K | 1 |
| Limpawattana, P | 1 |
| Mahankkanukrauh, A | 1 |
| Wongvipaporn, C | 1 |
| Garcia-Donaire, JA | 1 |
| Ruilope, LM | 1 |
| Thomas, MC | 1 |
| Ogawa, S | 1 |
| Mori, T | 1 |
| Nako, K | 1 |
| Ishizuka, T | 1 |
| Ito, S | 1 |
| Agodoa, LY | 1 |
| Francis, ME | 1 |
| Eggers, PW | 1 |
| Shrivastava, R | 1 |
| Khan, A | 1 |
| Jeevanantham, V | 1 |
| Nautiyal, A | 1 |
| Garg, P | 1 |
| Reddy, PC | 1 |
| Watanabe, Y | 1 |
| Suzui, J | 1 |
| Ichikawa, Y | 1 |
| Yoshida, K | 1 |
| Suzuki, H | 1 |
| Faas, MM | 1 |
| Schuiling, GA | 1 |
| Baller, JF | 1 |
| Valkhof, N | 1 |
| Bakker, WW | 1 |
| Gaede, PH | 1 |
| Jensen, BR | 1 |
| Rolka, DB | 1 |
| Fagot-Campagna, A | 1 |
| Narayan, KM | 1 |
| DeRubertis, FR | 1 |
| Craven, PA | 1 |
| Toppozada, M | 2 |
| Darwish, EA | 1 |
| Osman, YF | 1 |
| Abd-Rabbo, MS | 1 |
| Khowessah, M | 1 |
| Shaala, S | 1 |
| Abd-Rabbo, S | 1 |
| Zoheir, A | 1 |
| Hopper, AH | 1 |
| Tindall, H | 1 |
| Urquhart, S | 1 |
| Davies, JA | 1 |
| Husted, SE | 1 |
| Nielsen, HK | 1 |
| Petersen, T | 1 |
| Mogensen, CE | 1 |
| Geday, E | 1 |
| Chalmers, TM | 1 |
3 reviews available for aspirin and Albuminuria
| Article | Year |
|---|---|
Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.
Topics: Albuminuria; Antihypertensive Agents; Aspirin; Counseling; Diabetes Mellitus, Type 1; Diabetes Melli | 2012 |
Prevention and treatment of diabetic nephropathy in older patients.
Topics: Aged; Albuminuria; Antihypertensive Agents; Aspirin; Blood Glucose; Clinical Trials as Topic; Diabet | 2003 |
Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.
Topics: Albuminuria; Aspirin; Cardiovascular Diseases; Chronic Disease; Glomerular Filtration Rate; Humans; | 2006 |
8 trials available for aspirin and Albuminuria
| Article | Year |
|---|---|
Evaluation of the Effect of Low-Dose Aspirin on Biochemical and Biophysical Biomarkers for Placental Disease in Low-Risk Pregnancy: Secondary Analysis of a Multicenter RCT.
Topics: Adult; Albuminuria; Aspirin; Biomarkers; Creatinine; Female; Fetal Development; Humans; Placenta; Pl | 2019 |
Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Antihypertensive Agents; Aspirin; Blood Pressure; Chole | 2011 |
Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate.
Topics: Adult; Aged; Albuminuria; Aspirin; Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus, T | 2003 |
Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis Obliterans; Aspirin; Ch | 2008 |
Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuria.
Topics: Adult; Albuminuria; Aspirin; Blood Pressure; Chromatography, High Pressure Liquid; Cross-Over Studie | 2000 |
Low dose acetyl salicylic acid in severe preeclampsia.
Topics: Albuminuria; Aspirin; Blood Pressure; Edema; Female; Humans; Pre-Eclampsia; Pregnancy | 1991 |
Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus.
Topics: Adult; Albuminuria; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Drug Therapy, Combination; Hum | 1987 |
Clinical experience with Ibuprofen in the treatment of rheumatoid arthritis.
Topics: Albuminuria; Alkaline Phosphatase; Analgesics; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspa | 1969 |
14 other studies available for aspirin and Albuminuria
| Article | Year |
|---|---|
The association of frailty with chronic kidney disease in older adults using the ASPirin in reducing events in the elderly cohort.
Topics: Aged; Albuminuria; Aspirin; Cross-Sectional Studies; Frailty; Glomerular Filtration Rate; Humans; Re | 2023 |
Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway.
Topics: Albuminuria; Animals; Aspirin; Creatinine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; | 2019 |
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
Topics: Adult; Albuminuria; Aspirin; Blood Glucose; Cross-Sectional Studies; Cyclooxygenase 1; Diabetes Mell | 2016 |
Clinical determinants of aspirin resistance in diabetes.
Topics: Albuminuria; Aspirin; Cohort Studies; Diabetic Angiopathies; Drug Resistance; Female; Glycated Hemog | 2010 |
The rate of checking urine microalbumin and aspirin primary prevention in type 2 DM.
Topics: Albuminuria; Aspirin; Atherosclerosis; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Humans; Hyp | 2006 |
The assessment and management of albuminuria in primary care.
Topics: Aged; Albuminuria; Aspirin; Blood Glucose; Cardiovascular Diseases; Chronic Disease; Diabetes Mellit | 2008 |
Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults.
Topics: Acetaminophen; Adult; Aged; Albuminuria; Analgesics; Aspirin; Cross-Sectional Studies; Female; Glome | 2008 |
Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Albuminuria; Aspirin; Blood Pressure; Chol | 2008 |
[The effect of peripheral blood mononuclear cell products from children with nephrotic syndrome on thromboxane A2 metabolism].
Topics: Albuminuria; Animals; Aspirin; Blood Platelets; Cells, Cultured; Child; Female; Humans; Kidney Glome | 1995 |
Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apyrase; Aspirin; Blood Pressure; Cel | 1997 |
Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey.
Topics: Adult; Albuminuria; Angina Pectoris; Aspirin; Cardiovascular Diseases; Diabetes Complications; Diabe | 2001 |
Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat.
Topics: Albuminuria; Animals; Aspirin; Blood Platelets; Diabetes Mellitus, Experimental; Dinoprostone; Femal | 1992 |
Treatment of severe pre-eclampsia by acetyl salicylic acid.
Topics: Adolescent; Adult; Albuminuria; Aspirin; Blood Pressure; Body Temperature; Edema; Female; Humans; Hy | 1991 |
Acute effects of acetylsalicylic acid on renal and hepatic function in normal humans.
Topics: Adolescent; Adult; Alanine Transaminase; Albuminuria; Aspartate Aminotransferases; Aspirin; beta 2-M | 1985 |